OPTIMA Trial: Some Breast Cancer Patients May Avoid Chemo
Some women with high-risk, ER-positive, HER2-negative early breast cancer may be able to safely avoid chemotherapy, according to results from the OPTIMA trial presented at the 2026 American Society of Clinical Oncology (ASCO) annual meeting.
